Edition:
United States

Biotechnology & Medical Research

Page 1

Digirad, East Hill File Preliminary Proxy Statement Related To Aviragen, Vaxart Proposed Merger

Friday, 19 Jan 2018 03:14pm EST

Jan 19 (Reuters) - :DIGIRAD, EAST HILL FILE PRELIMINARY PROXY STATEMENT RELATED TO AVIRAGEN THERAPEUTICS, VAXART PROPOSED MERGER - SEC FILING.DIGIRAD, EAST HILL URGE AVIRAGEN THERAPEUTICS SHAREHOLDERS TO VOTE AGAINST CO'S PROPOSED MERGER WITH VAXART.

Miraca Life Sciences, Theradiag’s Partner In The US, Becomes Inform Diagnostics

Friday, 19 Jan 2018 02:01am EST

Jan 19 (Reuters) - Theradiag Sa ::MIRACA LIFE SCIENCES, THERADIAG’S PARTNER IN THE USA, BECOMES INFORM DIAGNOSTICS.‍US PARTNER MIRACA LIFE SCIENCES HAS CHANGED ITS NAME TO INFORM DIAGNOSTICS​.

BB Biotech to propose 3.30 Sfr dividend for 2017

Friday, 19 Jan 2018 01:00am EST

Jan 19 (Reuters) - BB Biotech AG ::SHOWS A DOUBLE-DIGIT TOTAL RETURN FOR 2017 - MID CAPS OVERDELIVER ON INNOVATION AND ARE BECOMING A KEY UPSIDE TRIGGER.‍UNDERLYING PORTFOLIO PERFORMED WELL, ENDING YEAR UP 23.4% IN CHF, 12.5% IN EUR AND 29.2% IN USD​.‍FULL YEAR 2017 DATA SHOWED A NET GAIN OF CHF 688 MN COMPARED TO A NET LOSS OF CHF 802 MN FOR FULL YEAR 2016​.‍WILL PROPOSE A RECORD REGULAR DIVIDEND OF CHF 3.30 PER SHARE AT GENERAL ASSEMBLY ON MARCH 13, 2018​.‍BELIEVES THAT 2018 WILL CONTINUE TO BRING IMPORTANT PRODUCT APPROVALS AND MILESTONES FOR SECTOR AND FOR ITS PORTFOLIO​.

Agios prices offering of 7.09 mln shares at $67 per share

Thursday, 18 Jan 2018 08:43pm EST

Jan 18 (Reuters) - Agios Pharmaceuticals Inc ::AGIOS ANNOUNCES PRICING OF $475 MILLION PUBLIC OFFERING OF COMMON STOCK.AGIOS PHARMACEUTICALS - ‍IT HAS PRICED AN UNDERWRITTEN PUBLIC OFFERING OF 7.09 MILLION SHARES OF COMMON STOCK AT A PRICE TO PUBLIC OF $67.00 PER SHARE​.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary